Nonlinear Materials Corporation (NLM) is a Seattle-based company specializing in advanced electro-optic (EO) materials and integration techniques. NLM has secured exclusive licenses for several key EO materials patents from the University of Washington, developed over 20 years of research and $20 million in R&D funding. The company's core technology allows chip and computer manufacturers to integrate low-power, high-speed optical computing components into their production processes. Additionally, NLM's plasmonic biosensors can detect specific chemical compounds, enabling tests for ricin poisoning, E. coli bacterial contamination, and antibodies indicating vaccine effectiveness. These biosensors are designed to be smaller, less expensive, and disposable, addressing a growing market that was valued at $1 billion in 2018 and is expected to reach $5 billion by 2025. NLM serves clients in the semiconductor and biotechnology industries, leveraging its proprietary materials and methods to deliver cutting-edge solutions. The company's business model focuses on licensing its technology and materials to manufacturers, generating revenue through licensing fees and royalties.

Keywords: electro-optic materials, optical computing, plasmonic biosensors, semiconductor, biotechnology, low-power, high-speed, disposable sensors, University of Washington, licensing.